Cargando…

Psychological complications in patients with acromegaly: relationships with sex, arthropathy, and quality of life

PURPOSE: Current treatment of acromegaly restores a normal life expectancy in most cases. So, the study of persistent complications affecting patients’ quality of life (QoL) is of paramount importance, especially motor disability and depression. In a large cohort of acromegalic patients we aimed at...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cangiano, Biagio, Giusti, Emanuele, Premoli, Caterina, Soranna, Davide, Vitale, Giovanni, Grottoli, Silvia, Cambria, Valeria, Mantovani, Giovanna, Mungari, Roberta, Maffei, Pietro, Dassie, Francesca, Giampietro, Antonella, Chiloiro, Sabrina, Tanda, Maria Laura, Ippolito, Silvia, Cannavò, Salvatore, Ragonese, Marta, Zambon, Antonella, Persani, Luca, Fatti, Letizia Maria, Scacchi, Massimo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385810/ https://www.ncbi.nlm.nih.gov/pubmed/35779206 http://dx.doi.org/10.1007/s12020-022-03106-8

Ejemplares similares

Are there country-specific differences in the use of pegvisomant for acromegaly in clinical practice? An analysis from ACROSTUDY
por: Grottoli, S., et al.
Publicado: (2022)

The Endothelium in Acromegaly
por: Maffei, Pietro, et al.
Publicado: (2019)

Pegvisomant in acromegaly: an update
por: Giustina, A., et al.
Publicado: (2017)

Cardiometabolic Risk in Acromegaly: A Review With a Focus on Pasireotide
por: Puglisi, Soraya, et al.
Publicado: (2020)

Analysis of Predictive Equations for Estimating Resting Energy Expenditure in a Large Cohort of Morbidly Obese Patients
por: Cancello, Raffaella, et al.
Publicado: (2018)

Multidimensional geriatric evaluation in acromegaly: a comparative cross-sectional study
por: Gagliardi, Irene, et al.
Publicado: (2021)

Global psychological assessment with the evaluation of life and sleep quality and sexual and cognitive function in a large number of patients with acromegaly: a cross-sectional study
por: Pivonello, Rosario, et al.
Publicado: (2022)

Questionnaire and tools: clinical powerful instrument in acromegaly diagnosis and management
por: Camerini, S., et al.
Publicado: (2022)

Use of Pegvisomant in acromegaly. An Italian Society of Endocrinology guideline
por: Giustina, A., et al.
Publicado: (2014)

Arthropathie destructrice des épaules au cours d'une acromégalie
por: Akasbi, Nessrine, et al.
Publicado: (2011)

Vitamin D and COVID-19 severity and related mortality: a prospective study in Italy
por: Campi, Irene, et al.
Publicado: (2021)

Glucose metabolism outcomes in acromegaly patients on treatment with pasireotide-LAR or pasireotide-LAR plus Pegvisomant
por: Chiloiro, Sabrina, et al.
Publicado: (2021)

ODP348 Regional disparities in functional impairment due to arthropathy in patients with acromegaly.
por: Ahmad, Syed, et al.
Publicado: (2022)

Serum NT-pro-BNP Levels Predict Cardiovascular Events in Acromegaly Patients
por: Ragonese, Marta, et al.
Publicado: (2021)

MON-311 Glucose Metabolism in Acromegaly Patients Resistant to First Generation Somatostatin Receptor Ligands Treated with Pegvisomant And/Or Pasireotide Lar
por: Chiloiro, Sabrina, et al.
Publicado: (2020)

Impact of the diagnostic delay of acromegaly on bone health: data from a real life and long term follow-up experience
por: Chiloiro, Sabrina, et al.
Publicado: (2022)

Partial response to first generation SSA guides the choice and predict the outcome of second line therapy in acromegaly
por: Chiloiro, Sabrina, et al.
Publicado: (2022)

The role of the dentist and orthodontist in recognizing oro-facial manifestations of acromegaly: a questionnaire-based study
por: Preo, Giorgia, et al.
Publicado: (2021)

SUN-LB075 Effects of Pegvisomant and Pasireotide LAR on Incidence of Vertebral Fractures in Patients with Acromegaly Resistant to Treatment with First-Line Somatostatin Analogs
por: Chiloiro, Sabrina, et al.
Publicado: (2019)

First but not second postoperative day growth hormone assessments as early predictive tests for long-term acromegaly persistence
por: Cambria, V., et al.
Publicado: (2021)

Determinants of the Lifestyle Changes during COVID-19 Pandemic in the Residents of Northern Italy
por: Cancello, Raffaella, et al.
Publicado: (2020)

Development of a questionnaire on nutritional knowledge for the obese hospitalized patient: the NUTRIKOB questionnaire
por: Mambrini, Sara Paola, et al.
Publicado: (2023)

Epidemiology, course, and outcomes of Sars-CoV-2 infection in patients with acromegaly and Cushing’s disease: a monocentric experience in Southern Italy
por: Ragonese, M., et al.
Publicado: (2023)

THU055 The Acro-TIME Score: A New Clinical, Pathological And Immune Integrative Approach To Early Identify Acromegaly Patients Resistant To Treatment With First Generation Somatostatin Ligands
por: Chiloiro, Sabrina, et al.
Publicado: (2023)

THU050 The Role Of The GH Receptor Polymorphism As Prognostic Factor Of Vertebral Fractures In Acromegaly Patients Resistant To First Generation SSAs And Treated With GH Receptor Antagonist Or Second Generation Somatostatin Ligand
por: Costanza, Flavia, et al.
Publicado: (2023)

Traumatic Brain Injury as Frequent Cause of Hypopituitarism and Growth Hormone Deficiency: Epidemiology, Diagnosis, and Treatment
por: Gasco, Valentina, et al.
Publicado: (2021)

Colon Cancer Presenting as Pituitary Mass and Hypopituitarism: Recognition and Multidisciplinary Approach of a Rare Case
por: Costanza, Flavia, et al.
Publicado: (2023)

Resistance to Somatostatin Analogs in Italian Acromegaly Patients: The MISS Study
por: Berton, Alessandro Maria, et al.
Publicado: (2022)

Vitamin D Status and SARS-CoV-2 Infection and COVID-19 Clinical Outcomes
por: Chiodini, Iacopo, et al.
Publicado: (2021)

A Clinical Experience of Pubertal Induction in Female Patients With Congenital Hypogonadotropic Hypogonadism (CHH) From an Endo-ERN Referral Center
por: Federici, Silvia, et al.
Publicado: (2021)

SGLT2 Inhibitors in the Management of Type 1 Diabetes (T1D): An Update on Current Evidence and Recommendations
por: Maffei, Pietro, et al.
Publicado: (2023)

Long-term effects of GH therapy in adult patients with Prader-Willi syndrome: a longitudinal study
por: Grugni, Graziano, et al.
Publicado: (2023)

Diabetes Secondary to Acromegaly: Physiopathology, Clinical Features and Effects of Treatment
por: Ferraù, Francesco, et al.
Publicado: (2018)

Comparative efficacy of three Bayesian variable selection methods in the context of weight loss in obese women
por: Pesenti, Nicola, et al.
Publicado: (2023)

Statins use and the risk of all and subtype hematological malignancies: a meta-analysis of observational studies
por: Pradelli, Danitza, et al.
Publicado: (2015)

Long-term remission of acromegaly after somatostatin analogues withdrawal: a single-centre experience
por: Sala, E., et al.
Publicado: (2021)

Three-dimensional path of the body centre of mass during walking in children: an index of neural maturation
por: Malloggi, Chiara, et al.
Publicado: (2019)

Gastrointestinal carcinoma first presenting as pituitary mass: recognition of a rare case and multidisciplinary approach for the management of pituitary metastases
por: Costanza, Flavia, et al.
Publicado: (2023)

GH/IGF-1 axis in a large cohort of ß-thalassemia major adult patients: a cross-sectional study
por: Gagliardi, I., et al.
Publicado: (2022)

Familial arthropathies
por: Al-Mayouf, Sulaiman
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_5n6bk1qkneaia6ja2qk1svvr02